Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects
- PMID: 15681626
- DOI: 10.1177/0891988704272308
Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects
Abstract
Cobalamin deficiency may cause cognitive deficits and even dementia. In Alzheimer's disease, the most frequent cause of dementia in elderly persons, low serum levels of vitamin B12, may be misleading. The aim of this work was to characterize the cognitive pattern of B12 deficiency and to compare it with that of Alzheimer's disease. Nineteen patients with low levels of vitamin B12 were neuropsychologically evaluated before treatment and a year later. Results were compared with those of 10 healthy control subjects. Final results suggest that there is a different pattern in both diseases. Twelve elderly patients with dementia improved with treatment. Seven elderly demented patients did not improve; they deteriorated after 1 year although their levels of cobalamin were normal. Analysis of the initial evaluation showed that the 2 groups of patients had a different neuropsychological profile. The group that improved had initially more psychotic problems and more deficits in concentration, visuospatial performance, and executive functions. They did not show language problems and ideomotor apraxia, which were present in the second group. Their memory pattern was also different. These findings suggest that cobalamin deficiency may cause a reversible dementia in elderly patients. This dementia may be differentiated from that of Alzheimer's disease by a thorough neuropsychological evaluation.
Similar articles
-
Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement.J Nutr Health Aging. 2002;6(4):254-60. J Nutr Health Aging. 2002. PMID: 12486445
-
Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.Neuropsychologia. 2008 Apr;46(5):1495-504. doi: 10.1016/j.neuropsychologia.2007.12.023. Epub 2008 Jan 5. Neuropsychologia. 2008. PMID: 18262206
-
[Vitamin B12 deficiency in geriatrics].Praxis (Bern 1994). 1999 Nov 4;88(45):1867-75. Praxis (Bern 1994). 1999. PMID: 10589285 Review. German.
-
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.Int J Geriatr Psychiatry. 2007 Dec;22(12):1217-22. doi: 10.1002/gps.1816. Int J Geriatr Psychiatry. 2007. PMID: 17562522
-
An update of vitamin B12 metabolism and deficiency states.J Fam Pract. 1995 Dec;41(6):595-600. J Fam Pract. 1995. PMID: 7500070 Review.
Cited by
-
Inferring multimodal latent topics from electronic health records.Nat Commun. 2020 May 21;11(1):2536. doi: 10.1038/s41467-020-16378-3. Nat Commun. 2020. PMID: 32439869 Free PMC article.
-
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.Int J Nanomedicine. 2015 Aug 4;10:4981-5003. doi: 10.2147/IJN.S87148. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26345528 Free PMC article.
-
Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's Disease.Int J Mol Sci. 2022 Jun 20;23(12):6855. doi: 10.3390/ijms23126855. Int J Mol Sci. 2022. PMID: 35743295 Free PMC article.
-
Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.Int J Dev Disabil. 2020;66(1):22-35. doi: 10.1080/20473869.2017.1301023. Epub 2017 Apr 9. Int J Dev Disabil. 2020. PMID: 33859818 Free PMC article.
-
Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs.J Diabetes Metab Disord. 2019 May 9;18(1):229-242. doi: 10.1007/s40200-019-00405-2. eCollection 2019 Jun. J Diabetes Metab Disord. 2019. PMID: 31275894 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical